Johnson & Johnson (NYSE:JNJ) changes shares on Friday trading session, with a change of 0.29% or $0.42 shares. The trading starts at $145.79 and closed at $143.41 throughout the day. The trading session low price was $143.25 and day high was $145.88 on Friday, June 19. After the session, the Healthcare sector daily volume shifted to 12.18 million while its average volume is 9.92M. In other hand, the JNJ market cap reached to $377.83B. While, its current target price is $143.83 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 1.18% and down -2.61% for month. Its quarterly performance was 19.97% above, while its half year performance is up 0.45%. JNJ yearly performance stood at positive 1.14% and fall -1.40% for year-to-date. Current recommendation for Johnson & Johnson is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. JNJ EPS (TTM) for 12-month is 6.41. EPS for this year is 0.50%, while for the next year its value is 9.05. Sales growth for the current quarter is 4.67 while its EPS Q/Q reached 56.20%. It has an EPS of -0.20% down for past five years and for the next five years will be up 4.80%.
Let’s take a look on the analyst recommendations on JNJ for the current month and previous month. For the current month, 11 of 20 analysts recommend stock as Buy while 0 as Sell, 2 as overweight, 1 as underweight and 6 as Hold. As compared with the previous month ratings, 19 analysts participate in stock recommendation. Out of 19, 0 rated it sell, 11 rated it as Buy and 5 as Hold Ratings. On the other hand, target price ranges from $133.00-$182.00. Average target price for JNJ was reached at $163.56.
Vanguard Group, Inc. (The), Blackrock Inc. and State Street Corporation are the top three holders in Johnson & Johnson (JNJ) stock. On Mar 30, 2020, Vanguard Group, Inc. (The) has 233.82 million shares which valued 30.66 billion. On Mar 30, 2020, Blackrock Inc. owned 192.55 million shares which valued at 25.25 billion. On Mar 30, 2020, State Street Corporation has a total of 151.55 million shares which valued at 19.87 billion. In the end, State Street Corporation have 5.75% shares outstanding of Johnson & Johnson (JNJ) on Mar 30, 2020. The insider ownership moved to 0.10% and institutional holding shifted to 70.80%.
The company posted an EPS (TTM) of 6.41. According to the most recent quarter report on (Jun 2020), 16 analysts estimated an average EPS of 1.47, while 2.58 EPS posted a year ago period. Analyst Estimated EPS for JNJ published in the report was 1.33-1.62 during the same period. Comparing with last year, the average estimated EPS was 2.58 which is higher than 2.3 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for JNJ rise 2.74% for period of 200 days. SMA for 50 days was -2.56% which is showing red signal, while SMA-20 was -1.18%. The moving average value for Johnson & Johnson (JNJ) is 143.89 and 146.64 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in JNJ stock. On Mar 13, PEREZ WILLIAM D, Director, bought 500 trading shares at the cost of $127.69, which valued at 63843.0. On Feb 21, Mongon Thibaut, Exec VP, WW Chair, Consumer, sold 39,224 shares at the cost of $147.96, with total shares of 35,815. On Jan 30, Sneed Michael E, EVP, Global Corp Aff & COO, sold 58,128 shares at the cost of 149.39. After this transaction, Sneed Michael E total shares reached to 49,383 which valued at 8.68 million.